EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Limitations of CAR-T-Cell Therapy in Hematologic Malignancies: Focusing on Antigen Escape and T-Cell Dysfunction

Yanyu Lin, Shuqi Luo, Jianhui Wei iD, Shujin Lin, Dawei Wang, Xiangqian Zhao, Zexin Feng, Yangkun Shen iD, Qi Chen iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26199669 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Yanyu Lin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, College of Life Science, Qishan Campus, Fujian Normal Univ…. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Immunotherapy, Adoptive, T-Lymphocytes, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 222 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Fujian Province, Innovation of Science and Technology, Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor T (CAR-T)-cell therapy has revolutionized the treatment of hematological malignancies, yet long-term efficacy remains constrained by antigen escape and T-cell dysfunction. Recent advances have rapidly elucidated the molecular underpinnings of antigen escape mechanisms and intrinsic T-cell dysfunction, revealing novel vulnerabilities in current CAR-T paradigms. In this review, we discuss the limitations of CAR-T-cell therapy in hematological malignancies, particularly regarding antigen escape mechanisms and T-cell dysfunction. It is noteworthy that in recent years, multi-targeted CAR-T and engineered CAR-T cells have demonstrated promising clinical efficacy in overcoming drug resistance and relapse in hematological malignancies. Here, we also discuss emerging approaches to enhance the efficacy of CAR-T-cell therapy, including advanced CAR-T-cell engineering techniques, the identification of novel therapeutic targets, and the development of multi-targeted CAR-T-cell strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic NeoplasmsImmunotherapy, AdoptiveT-LymphocytesReceptors, Chimeric AntigenTumor EscapeHumansAnimalsReceptors, Antigen, T-CellAntigens, Neoplasm

Stichwörter der Autor:innen

CAR-TT-cell dysfunctionantigen escapehematologic malignancies

Substanzen

Receptors, Chimeric AntigenReceptors, Antigen, T-CellAntigens, Neoplasm

Autor:innen und Institutionen

  • Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, College of Life Science, Qishan Campus, Fujian Normal University, Fuzhou 350117, China.
  • State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen 361102, China.

ORCID-Profile: Jianhui Wei, Yangkun Shen, Qi Chen

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Fujian Province
  • Innovation of Science and Technology, Fujian Province
  • Fujian Cancer Hospital Subject

Zitieren

APA

Lin, Y., Luo, S., Wei, J., Lin, S., Wang, D., Zhao, X., Feng, Z., Shen, Y., & Chen, Q. (2025). Limitations of CAR-T-Cell Therapy in Hematologic Malignancies: Focusing on Antigen Escape and T-Cell Dysfunction. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26199669

Vancouver

Lin Y, Luo S, Wei J, Lin S, Wang D, Zhao X, et al. Limitations of CAR-T-Cell Therapy in Hematologic Malignancies: Focusing on Antigen Escape and T-Cell Dysfunction. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26199669

BibTeX
@article{Lin2025,
  author = {Lin, Yanyu and Luo, Shuqi and Wei, Jianhui and Lin, Shujin and Wang, Dawei and Zhao, Xiangqian and Feng, Zexin and Shen, Yangkun and Chen, Qi},
  title = {Limitations of CAR-T-Cell Therapy in Hematologic Malignancies: Focusing on Antigen Escape and T-Cell Dysfunction},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26199669}
}
Kostenlos starten →